Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2016 Mar-2015 Mar-2014 Jan-1970
Growth matrix (%)        
Revenue growth (6.60) 1.21 -- --
Op profit growth 99.90 (40) -- --
EBIT growth 7,946 (105) -- --
Net profit growth (590) (73) -- --
Profitability ratios (%)        
OPM 12.70 5.95 9.99 --
EBIT margin 20.90 0.24 (5) --
Net profit margin 12.80 (2.40) (9.10) --
RoCE 224 2.86 -- --
RoNW 1.90 (0.40) -- --
RoA 1.47 (0.30) -- --
Per share ratios ()        
EPS 3.25 -- -- --
Dividend per share -- -- -- --
Cash EPS 2.86 (3.50) (6.80) --
Book value per share 44.40 41.10 42 --
Valuation ratios        
P/E 11.80 -- -- --
P/CEPS 13.40 (3.10) (1.50) --
P/B 0.86 0.27 0.23 --
EV/EBIDTA 5.66 (3.30) 5.32 --
Payout (%)        
Dividend payout -- -- -- --
Tax payout (30) (84) 4.11 --
Liquidity ratios        
Debtor days 200 142 -- --
Inventory days 76.70 65.20 -- --
Creditor days (108) (67) -- --
Leverage ratios        
Interest coverage (7.70) (0.10) 1.33 --
Net debt / equity (0.10) (0.50) 0.14 --
Net debt / op. profit (1.80) (13) 2.21 --
Cost breakup ()        
Material costs (52) (63) (57) --
Employee costs (13) (13) (14) --
Other costs (22) (18) (19) --
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2016 Mar-2015 Mar-2014 Jan-1970
Revenue 53.60 57.40 56.70 --
yoy growth (%) (6.60) 1.21 -- --
Raw materials (28) (36) (32) --
As % of sales 52 62.90 56.60 --
Employee costs (7.20) (7.60) (8) --
As % of sales 13.40 13.30 14 --
Other costs (12) (10) (11) --
As % of sales 21.80 17.90 19.40 --
Operating profit 6.83 3.42 5.66 --
OPM 12.70 5.95 9.99 --
Depreciation (0.80) (6.10) (9.10) --
Interest expense (1.40) (1.70) (2.10) --
Other income 5.18 2.79 0.57 --
Profit before tax 9.74 (1.60) (5) --
Taxes (2.90) 1.31 (0.20) --
Tax rate (30) (84) 4.11 --
Minorities and other -- -- -- --
Adj. profit 6.85 (0.20) (5.20) --
Exceptional items -- (1.10) -- --
Net profit 6.85 (1.40) (5.20) --
yoy growth (%) (590) (73) -- --
NPM 12.80 (2.40) (9.10) --
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2016 Mar-2015 Mar-2014 Jan-1970
Profit before tax 9.74 (1.60) (5) --
Depreciation (0.80) (6.10) (9.10) --
Tax paid (2.90) 1.31 (0.20) --
Working capital 44.70 -- -- --
Other operating items -- -- -- --
Operating cashflow 50.70 (6.30) -- --
Capital expenditure (67) -- -- --
Free cash flow (17) (6.30) -- --
Equity raised 133 132 -- --
Investments 12.20 -- -- --
Debt financing/disposal 1.24 -- -- --
Dividends paid -- -- -- --
Other items -- -- -- --
Net in cash 130 126 -- --
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2016 Mar-2015 Mar-2014 Jan-1970
Equity capital 21 21 21 --
Preference capital -- -- -- --
Reserves 72.40 65.50 67.30 --
Net worth 93.40 86.60 88.30 --
Minority interest
Debt 24.20 28.60 23 --
Deferred tax liabilities (net) -- -- 1.40 --
Total liabilities 118 115 113 --
Fixed assets 14.70 4.87 73.10 --
Intangible assets
Investments 12.20 10.10 -- --
Deferred tax asset (net) 0.05 0.09 -- --
Net working capital 54.20 27.90 29.10 --
Inventories 15 7.52 13 --
Inventory Days 102 47.80 83.70 --
Sundry debtors 34.30 24.50 20.10 --
Debtor days 234 156 129 --
Other current assets 31.50 9.12 10.10 --
Sundry creditors (19) (9) (11) --
Creditor days 127 57.40 69.10 --
Other current liabilities (8) (4.20) (3.30) --
Cash 36.60 72.10 10.50 --
Total assets 118 115 113 --
Switch to
Consolidated
Standalone


Alpa Laboratories Ltd Report not showing data